A fentanyl vaccine is about to get its first major test

Ars TechnicaThursday, December 4, 2025 at 11:30:04 AM
PositiveTechnology
A fentanyl vaccine is about to get its first major test
  • A significant trial for a fentanyl vaccine is set to take place in the Netherlands, aiming to provide protection against fentanyl-related overdoses and deaths. This initiative is spearheaded by ARMR Sciences, a New York-based company, marking a pivotal moment in the fight against the opioid crisis.
  • The development of this vaccine is crucial as it represents a proactive approach to combating the rising number of fentanyl overdoses, which have become a pressing public health issue. Successful outcomes from this trial could pave the way for broader applications and solutions to the opioid epidemic.
  • The emergence of new synthetic opioids, such as nitazenes, which are significantly more potent than fentanyl, underscores the urgency of this vaccine trial. As the opioid crisis evolves, innovative solutions like this vaccine are essential to address the escalating threats posed by increasingly dangerous substances.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
"A disaster waiting to happen" – The privacy tech world reacts to the new Chat Control bill
NegativeTechnology
The EU Council has reached an agreement on a new Chat Control bill that includes voluntary scanning for Child Sexual Abuse Material (CSAM), but countries like Italy, the Czech Republic, Poland, and the Netherlands remain opposed to this compromise. Privacy experts have expressed significant concerns, describing the situation as a potential disaster for user privacy.
A Fentanyl Vaccine Is About to Get Its First Major Test
PositiveTechnology
ARMR Sciences, based in New York, is set to conduct a major trial of a vaccine designed to protect against fentanyl-related overdoses and deaths in the Netherlands. This initiative marks a significant step in addressing the ongoing opioid crisis and the dangers associated with fentanyl use.
EU Court gives the Dutch the green light to pursue Apple App Store anti-trust case
PositiveTechnology
The European Court of Justice has ruled that the Netherlands can proceed with its anti-trust case against Apple regarding its App Store commissions, marking a significant step in the ongoing scrutiny of Apple's business practices in Europe.